Issue: Volume XXVIII, No. 10 - July 26, 2021

Goodbye Clinical Labs! Hello Genetic Testing Labs!

IS THE CLASSIC MODEL OF THE INDEPENDENT PATHOLOGIST-OWNED CLINICAL LABORATORY that is the sole source provider of all routine, reference, and esoteric testing to physicians in its community on its way to extinction? There is strong evidence to support a “yes” answer to that question.  The heyday of the local, pathologist-owned independent lab company was …

Goodbye Clinical Labs! Hello Genetic Testing Labs! Read More »

Artificial Intelligence Is Ready to Deliver for Labs

CEO SUMMARY: Artificial intelligence (AI) may be one of the most over-used terms to describe a host of different applications, software tools, and products. However, during the past year, some truly revolutionary digital tools are now in use by a small number of innovative clinical laboratories. These applications are being used to improve operational work …

Artificial Intelligence Is Ready to Deliver for Labs Read More »

CLIA Accreditation Market: More Competitive Now?

CEO SUMMARY: It’s been three decades since compliance with the Clinical Laboratory Improvement Amendments (CLIA) became mandatory. During that time, there has been little competition among the major organizations with deeming status by the Medicare Program to accredit labs to CLIA. However, decisions by several major health systems to change the CLIA-accreditation provider they had …

CLIA Accreditation Market: More Competitive Now? Read More »

How to Achieve Success with Genetic Test Prior Authorization

AS MANAGED CARE PAYERS INCREASINGLY REQUIRE PRIOR AUTHORIZATION FOC GENETIC TESTS, clinical laboratories should understand the ins and outs of what it takes to get reimbursed for testing they provide.  Almost all payers now require prior authorization (PA) for genetic testing, said Heather Agostinelli, Vice President, strategic revenue operations, with XIFIN Inc., a revenue cycle …

How to Achieve Success with Genetic Test Prior Authorization Read More »

PacBio Beefs Up with Purchase of Omniome for $800 Million

FORWARD-LOOKING PATHOLOGISTS AND LAB ADMINISTRATORS understand that the next big game in medical laboratory testing will be assays built upon genome sequencing. They also know that several companies are racing to produce gene sequencing instruments that are faster, simpler, and less costly in order to serve the needs of clinical labs.  Currently, Illumina, Inc., of …

PacBio Beefs Up with Purchase of Omniome for $800 Million Read More »

July 26, 2021 Intelligence: Late-Breaking Lab News

Intermountain Healthcare of Salt Lake City announced that it plans to close 25 of its 26 retail pharmacies as early as next month. It cited declining business and a new business arrangement with CVS Health, the national pharmacy chain. Daron Crowley, Intermountain’s media relations director, told the Salt Lake City Tribune that “they aren’t being …

July 26, 2021 Intelligence: Late-Breaking Lab News Read More »

;